ORAL ULCERS IN SYSTEMIC LUPUS ERYTHEMATOSUS – RELATIONSHIP WITH DISEASE DURATION AND SEVERITY
DOI:
https://doi.org/10.33279/jkcd.v10i01.305Keywords:
Systemic Lupus Erythematosus, oral ulcer, American College of Rheumatology, prevalence, PakistanAbstract
Objective: This study was conducted to assess the prevalence of oral ulceration among systemic lupus erythematosus patients in Pakistan and their relationship with disease duration and severity.
Materials & Methods: This cross-sectional study was conducted at Clinic for Arthritis and Rheumatic Diseases, DHQ Hospital, Rawalpindi Medical University, Pakistan. 75 adult patients, fulfilling the 1997 American College of Rheumatology diagnostic criteria for SLE, between January and December 2018 were included in the study. Clinical signs comprising of oral cavity were documented and their relationship to disease duration in years and organ damage using SLICC/ACR-DI score was studied. Descriptive statistics and logistic regression analysis were performed for statistical assessment.
Results: 75 patients with SLE were included in the study. Female to male ratio was 9.5:1 (94.7% females and 5.3% males) and mean age of patients was 30.65 ± 10.71 years. 34 patients (45.3%) had oral ulcers. No significant association was observed between presence of oral ulcers with age (p-value= 0.43), with gender (p-value= 0.618) and disease duration (p-value=0.10). However, mean SLICC/ACR-DI score for SLE patients with oral ulcers was 2.0 as compared to 0.8 for the patients without oral ulcers (p-value=0.001).
Conclusion: This study found that Pakistani patients with SLE have high prevalence (45.3%) of oral ulceration, especially in patients with poorly controlled disease and more evidence of organ damage. This warrants the need to create awareness about disease among healthcare workers and patients.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Shamaila Mumtaz, Misbah Ali, Nauman Bari Khan, Benish Mehmood, Muhammad Azhar, Farah Farhan

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.




